Hesperidin Loaded on Gold Nanoparticles as a Drug Delivery System for a Successful Biocompatible, Anti-Cancer, Anti-Inflammatory and Phagocytosis Inducer Model

• Published in: Scientific reports 2020-06, Vol.10 (1), p.9362, Article 9362
• Main Authors: Sulaiman, Ghassan M., Waheeb, Hanaa M., Jabir, Majid S., Khazaal, Shaymaa H., Dewir, Yaser Hassan, Naidoo, Yougasphree
• Format: Article
• Language: English
• Subjects: 631/154; 631/1647; 631/61; 631/67; Acridine orange; Animals; Anti-Inflammatory Agents - chemistry; Anti-Inflammatory Agents - pharmacology; Antineoplastic Agents - chemistry; Antineoplastic Agents - pharmacology; Apoptosis; Ascites; Ascites tumor cells; Bioavailability; Bone marrow; Breast cancer; Cancer; Cell proliferation; Cytotoxicity; Drug Carriers - chemistry; Drug delivery; Drug Liberation; Ehrlich ascites tumor; Ehrlich ascites tumor cells; Epithelial cells; Flavonoids; Gold; Gold - chemistry; Hesperidin; Hesperidin - chemistry; Hesperidin - pharmacology; Humanities and Social Sciences; Humans; Inflammation; Interleukin 6; Iodides; Kidneys; Macrophages; Male; Materials Testing; Metal Nanoparticles - chemistry; Mice; multidisciplinary; Nanoparticles; Oxidative Stress - drug effects; Phagocytosis; Phagocytosis - drug effects; Science; Science (multidisciplinary); Spleen; Statistical analysis; Tumor cells; Ultraviolet spectroscopy; Zeta potential
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-66419-6

Hesperidin is a flavonoid glycoside with proven therapeutic activities for various diseases, including cancer. However, its poor solubility and bioavailability render it only slightly absorbed, requiring a delivery system to reach its therapeutic target. Hesperidin loaded on gold nanoparticles (Hsp-AuNPs) was prepared by a chemical synthesis method. Various characterization techniques such as UV-VIS spectroscopy, FTIR, XRD, FESEM, TEM and EDX, Zeta potential analysis, particle size analysis, were used to confirm the synthesis of Hsp-AuNPs. The cytotoxic effect of Hsp-AuNPs on human breast cancer cell line (MDA-MB-231) was assessed using MTT and crystal violet assays. The results revealed significant decrease in proliferation and inhibition of growth of the treated cells when compared with human normal breast epithelial cell line (HBL-100). Determination of apoptosis by fluorescence microscope was also performed using acridine orange-propidium iodide dual staining assay. The in vivo study was designed to evaluate the toxicity of Hsp-AuNPs in mice. The levels of hepatic and kidney functionality markers were assessed. No significant statistical differences were found for the tested indicators. Histological images of liver, spleen, lung and kidney showed no apparent damages and histopathological abnormalities after treatment with Hsp-AuNPs. Hsp-AuNPs ameliorated the functional activity of macrophages against Ehrlich ascites tumor cells-bearing mice. The production of the pro-inflammatory cytokines was also assessed in bone marrow–derived macrophage cells treated with Hsp-AuNPs. The results obviously demonstrated that Hsp-AuNPs treatment significantly inhibited the secretion of IL-1β, IL-6 and TNF.